FMED Price Forecast & ETF Analysis. Dividend · Expense Ratio · Holdings · NAV · RSI · MACD

FMED

Fidelity Disruptive Medicine ETF

At close Oct 23 at 11:23 AM ET (Korea 10/24 24:23)

$31.62

-0.37 ▼ -1.17%

Ascending Triangle Resistance 32.62 Support 30.45 Holding Same lines for 2 days Lines drawn by AI for reference. They may be wrong. Treat them as a hint, not a forecast.

Full metrics table

Category ⓘ	US Equities - Industry Sector	Expense ⓘ	0.5%	Return% 1Y ⓘ	20.64%	Total Holdings ⓘ	77	Perf Week ⓘ	1.23%	Volume ⓘ	3,396
Asset Type ⓘ	Equities (Stocks)	AUM ⓘ	$52M	Return% 3Y ⓘ	14.34%	NAV ⓘ	$32.07	Perf Month ⓘ	0.1%	Avg Volume ⓘ	0.01M
ETF Type ⓘ	US Equities	Dividend TTM ⓘ	-	Return% 5Y ⓘ	-	52W High ⓘ	-4.14%	Perf Quarter ⓘ	11.52%	Rel Volume ⓘ	0.47
Active/Passive ⓘ	Active	Div Gr. 3/5Y ⓘ	-	Return% 10Y ⓘ	-	52W Low ⓘ	34.66%	Perf Half Y ⓘ	25.57%	Prev Close ⓘ	$31.99
IPO ⓘ	2023/6/12	Flows% 1M ⓘ	0%	Return% SI ⓘ	7.4%	RSI (14) ⓘ	51.93	Perf YTD ⓘ	16.89%	Price ⓘ	$31.62
Beta ⓘ	0.77	Flows% 3M ⓘ	0%	Flows% YTD ⓘ	-24.8%	Flows% 1Y ⓘ	-21.65%	Perf Year ⓘ	19.9%	Volatility(W/M) ⓘ	2.49% 2%
SMA20 ⓘ	0.42%	SMA50 ⓘ	0.05%	SMA200 ⓘ	14.42%	ATR ⓘ	0.71

About this ETF

Fidelity Disruptive Medicine ETFFMED | NASD | Actively managed Deep dive

Fidelity Disruptive Medicine ETF seeks long-term growth of capital. The fund normally invests at least 80% of assets in securities of disruptive medicine companies. Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers. Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time. The fund is non-diversified.

FMED at a glance

0.5% Lower is better

$52M Assets Under Management

Listed 2023

Management Style Actively managed

Issuer Fidelity

Top Holdings 77 holdings

The top 10 make up 40% of the fund